GSK boss Emma Walmsley steels for survival fight with Elliott

Embattled GlaxoSmithKline boss Emma Walmsley expected to reinforce her defences against Elliott when pharma giant posts improving revenues By Alex Lawson, Financial Mail On Sunday Published: 16:50 EDT, 24 July 2021 | Updated: 16:50 EDT, 24 July 2021 Embattled GlaxoSmithKline chief Emma Walmsley is expected to reinforce her defences against corporate raider Elliott this week … Read more

Top investor Aviva fires warning shot at GSK boss Emma Walmsley

Top investor fires warning shot at GSK boss Walmsley as she prepares to fight off Wall Street raiders: Jury is still out on her future, declares Aviva By Matt Oliver For The Daily Mail Published: 21:59 BST, 17 May 2021 | Updated: 22:06 BST, 17 May 2021 Glaxosmithkline boss Emma Walmsley has been put on … Read more

GSK boss Emma Walmsley bids to defy raid by Elliott

GlaxoSmithKline boss Emma Walmsley will defend drugs giant’s strategy as she seeks to head off a raid by ‘vulture lord’ of Wall Street Walmsley is bracing for an assault after it emerged Paul Singer’s Elliott Management has taken a ‘multi-billion pound’ stake in GSK Elliott has remained silent about its intentions – but the hedge fund … Read more

ALEX BRUMMER: GSK boss braces for action over activist investor

ALEX BRUMMER: Activist investor Elliott’s arrival on the doorstep of GSK may require boss Emma Walmsley to strengthen the defences By Alex Brummer for the Daily Mail Published: 22:17 BST, 15 April 2021 | Updated: 22:17 BST, 15 April 2021 The arrival of activist investor Elliott Management on the doorstep of Glaxosmithkline’s glistening headquarters in … Read more

GSK forms new deal with CureVac to make Covid variant vaccines

GSK strikes £132m deal with CureVac to develop vaccines for Covid variants as it reveals lacklustre annual results A total of £132m will be invested by GlaxoSmithKline into CureVac’s research Demand for GSK-made pain relief and digestive health products grew strongly GSK’s largest division, Pharmaceuticals, saw its sales drop 3% to £17.1bn  By Harry Wise … Read more

GSK Covid vaccine is delayed

GSK Covid jabs won’t be ready until end of 2021: 60m doses ordered by UK government are delayed after British pharmaceutical giant GlaxoSmithKline sees poor response in elderly at trials The UK in July secured 60million doses of the treatment among other jabs  Any Sanofi/GSK jab will now not likely be ready before the end … Read more

British drug giants Astrazeneca and GSK still in race for a Covid jab

British drug giants Astrazeneca and Glaxosmithkline still in the race for a Covid jab By Matt Oliver For The Daily Mail Published: 21:53 GMT, 9 November 2020 | Updated: 22:20 GMT, 9 November 2020 Britain’s two biggest drugs companies are also developing Covid-19 vaccines. Potential jabs are being tested by FTSE 100 giants Astrazeneca and … Read more

GSK gears up for trials as it pushes ahead with three possible Covid-19 vaccines

GSK gears up for trials as it pushes ahead with three possible Covid-19 vaccines and two antibody treatments The British drugs group is also shipping record amounts of flu jabs  GSK warned that the pandemic continued to disrupt other parts of its business  But the firm said it would still pay out a dividend, expected … Read more

Chief Scientific Officer Sir Patrick Vallance has £600,000 of shares in vaccine maker GSK

Conflict of interest row as it emerges Chief Scientific Officer Sir Patrick Vallance has £600,000 of shares in vaccine maker contracted to make UK’s coronavirus jabs Sir Patrick was president of multinationals drugs giant GSK from 2012 to 2018 Chief Scientific Adviser holds a deferred bonus of 43,111 shares worth £600,000 He has already cashed in … Read more